These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21789163)

  • 1. Effectiveness of the AS03-adjuvanted vaccine against pandemic influenza virus A/(H1N1) 2009--a comparison of two methods; Germany, 2009/10.
    Uphoff H; An der Heiden M; Schweiger B; Campe H; Beier D; Helmeke C; Littmann M; Haas W; Buda S; Faensen D; Feig M; Altmann D; Wichmann O; Eckmanns T; Buchholz U
    PLoS One; 2011; 6(7):e19932. PubMed ID: 21789163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.
    Skowronski DM; Janjua NZ; De Serres G; Hottes TS; Dickinson JA; Crowcroft N; Kwindt TL; Tang P; Charest H; Fonseca K; Gubbay JB; Bastien N; Li Y; Petric M
    BMJ; 2011 Feb; 342():c7297. PubMed ID: 21292718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study.
    Steens A; Wijnans EG; Dieleman JP; Sturkenboom MC; van der Sande MA; van der Hoek W
    BMC Infect Dis; 2011 Jul; 11():196. PubMed ID: 21767348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England.
    Andrews N; Waight P; Yung CF; Miller E
    J Infect Dis; 2011 Jan; 203(1):32-9. PubMed ID: 21148494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway.
    Guzmán Herrador BR; Aavitsland P; Feiring B; Riise Bergsaker MA; Borgen K
    BMC Infect Dis; 2012 Mar; 12():63. PubMed ID: 22429643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France.
    Pelat C; Falchi A; Carrat F; Mosnier A; Bonmarin I; Turbelin C; Vaux S; van der Werf S; Cohen JM; Lina B; Blanchon T; Hanslik T
    PLoS One; 2011 May; 6(5):e19621. PubMed ID: 21573005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany.
    Remschmidt C; Rieck T; Bödeker B; Wichmann O
    BMC Infect Dis; 2015 Mar; 15():137. PubMed ID: 25887460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine.
    Simpson CR; Ritchie LD; Robertson C; Sheikh A; McMenamin J
    Health Technol Assess; 2010 Jul; 14(34):313-46. PubMed ID: 20630126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants.
    Ahmed SS; Schur PH; MacDonald NE; Steinman L
    J Autoimmun; 2014 May; 50():1-11. PubMed ID: 24559657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children.
    Gilca R; Deceuninck G; De Serres G; Boulianne N; Sauvageau C; Quach C; Boucher FD; Skowronski DM
    Pediatrics; 2011 Nov; 128(5):e1084-91. PubMed ID: 21987710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010.
    Fielding JE; Grant KA; Garcia K; Kelly HA
    Emerg Infect Dis; 2011 Jul; 17(7):1181-7. PubMed ID: 21762570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.
    Mahmud S; Hammond G; Elliott L; Hilderman T; Kurbis C; Caetano P; Van Caeseele P; Kettner J; Dawood M
    Vaccine; 2011 Oct; 29(45):7975-81. PubMed ID: 21884747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities.
    Griffin MR; Monto AS; Belongia EA; Treanor JJ; Chen Q; Chen J; Talbot HK; Ohmit SE; Coleman LA; Lofthus G; Petrie JG; Meece JK; Hall CB; Williams JV; Gargiullo P; Berman L; Shay DK;
    PLoS One; 2011; 6(8):e23085. PubMed ID: 21857999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls.
    Hellenbrand W; Jorgensen P; Schweiger B; Falkenhorst G; Nachtnebel M; Greutélaers B; Traeder C; Wichmann O
    BMC Infect Dis; 2012 May; 12():127. PubMed ID: 22650369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Did the H1N1 Vaccine Reduce the Risk of Admission with Influenza and Pneumonia during the Pandemic?
    Mahmud SM; Bozat-Emre S; Hammond G; Elliott L; Van Caeseele P
    PLoS One; 2015; 10(11):e0142754. PubMed ID: 26600435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial.
    Dikow R; Eckerle I; Ksoll-Rudek D; Hampel H; Schwenger V; Zeier M; Schnitzler P; Sommerer C
    Am J Kidney Dis; 2011 May; 57(5):716-23. PubMed ID: 21349617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines.
    Hauser MI; Muscatello DJ; Soh ACY; Dwyer DE; Turner RM
    Vaccine; 2019 Jul; 37(31):4246-4255. PubMed ID: 31253447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.